Insider · CIK 1488864
Ira Duarte
- Officer at Heron Therapeutics HRTX: 1 buys, 0 sales
- Director at TerrAscend TSNDF: 0 buys, 0 sales
- CAO at Company with CIK 1145404: 0 buys, 0 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys1
Open-market sales0
Bought$76K
Sold$0
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Oct 31, 2026 | Heron Therapeutics HRTX | Option exercise 11,695 sh 4 days after the company's S-8 filed Oct 27, 2026. | 306,051 | 4 days after the company's S-8 filed Oct 27, 2026. | |
| Oct 31, 2026 | Heron Therapeutics HRTX | Tax withholding 3,327 sh at $0.28 4 days after the company's S-8 filed Oct 27, 2026. | $932 | 302,724 | 4 days after the company's S-8 filed Oct 27, 2026. |
| Oct 30, 2026 | Heron Therapeutics HRTX | Option exercise 13,535 sh 3 days after the company's S-8 filed Oct 27, 2026. | 298,206 | 3 days after the company's S-8 filed Oct 27, 2026. | |
| Oct 30, 2026 | Heron Therapeutics HRTX | Tax withholding 3,850 sh at $0.28 3 days after the company's S-8 filed Oct 27, 2026. | $1K | 294,356 | 3 days after the company's S-8 filed Oct 27, 2026. |
| Oct 19, 2026 | Heron Therapeutics HRTX | Option exercise 3,874 sh 20 days after the company's 8-K filed Sep 29, 2026. | 285,773 | 20 days after the company's 8-K filed Sep 29, 2026. | |
| Oct 19, 2026 | Heron Therapeutics HRTX | Tax withholding 1,102 sh at $0.36 20 days after the company's 8-K filed Sep 29, 2026. | $397 | 284,671 | 20 days after the company's 8-K filed Sep 29, 2026. |
| Jul 31, 2026 | Heron Therapeutics HRTX | Option exercise 11,694 sh 36 days after the company's 8-K filed Jun 25, 2026. | 285,225 | 36 days after the company's 8-K filed Jun 25, 2026. | |
| Jul 31, 2026 | Heron Therapeutics HRTX | Tax withholding 3,326 sh at $0.50 36 days after the company's 8-K filed Jun 25, 2026. | $2K | 281,899 | 36 days after the company's 8-K filed Jun 25, 2026. |
| Jul 30, 2026 | Heron Therapeutics HRTX | Option exercise 13,535 sh 35 days after the company's 8-K filed Jun 25, 2026. | 277,381 | 35 days after the company's 8-K filed Jun 25, 2026. | |
| Jul 30, 2026 | Heron Therapeutics HRTX | Tax withholding 3,850 sh at $0.50 35 days after the company's 8-K filed Jun 25, 2026. | $2K | 273,531 | 35 days after the company's 8-K filed Jun 25, 2026. |
| Jul 19, 2026 | Heron Therapeutics HRTX | Option exercise 3,874 sh 24 days after the company's 8-K filed Jun 25, 2026. | 264,947 | 24 days after the company's 8-K filed Jun 25, 2026. | |
| Jul 19, 2026 | Heron Therapeutics HRTX | Tax withholding 1,101 sh at $0.47 24 days after the company's 8-K filed Jun 25, 2026. | $517 | 263,846 | 24 days after the company's 8-K filed Jun 25, 2026. |
| Jun 16, 2026 | Heron Therapeutics HRTX | Option exercise 12,500 sh The same day as the company's 8-K filed Jun 16, 2026. | 264,628 | The same day as the company's 8-K filed Jun 16, 2026. | |
| Jun 16, 2026 | Heron Therapeutics HRTX | Tax withholding 3,555 sh at $0.38 The same day as the company's 8-K filed Jun 16, 2026. | $1K | 261,073 | The same day as the company's 8-K filed Jun 16, 2026. |
| Apr 30, 2026 | Heron Therapeutics HRTX | Option exercise 11,694 sh The same day as the company's DEFA14A filed Apr 30, 2026. | 227,570 | The same day as the company's DEFA14A filed Apr 30, 2026. | |
| Apr 30, 2026 | Heron Therapeutics HRTX | Option exercise 13,535 sh The same day as the company's DEFA14A filed Apr 30, 2026. | 252,128 | The same day as the company's DEFA14A filed Apr 30, 2026. | |
| Apr 19, 2026 | Heron Therapeutics HRTX | Option exercise 3,874 sh 13 days after the company's 8-K filed Apr 6, 2026. | 215,876 | 13 days after the company's 8-K filed Apr 6, 2026. | |
| Jan 31, 2026 | Heron Therapeutics HRTX | Option exercise 11,695 sh 1 day after the company's SCHEDULE 13G filed Jan 30, 2026. | 195,356 | 1 day after the company's SCHEDULE 13G filed Jan 30, 2026. | |
| Jan 19, 2026 | Heron Therapeutics HRTX | Option exercise 3,875 sh 10 days after the company's 8-K filed Jan 9, 2026. | 183,661 | 10 days after the company's 8-K filed Jan 9, 2026. | |
| Oct 31, 2025 | Heron Therapeutics HRTX | Option exercise 11,694 sh 1 day after the company's SCHEDULE 13G/A filed Oct 30, 2025. | 179,786 | 1 day after the company's SCHEDULE 13G/A filed Oct 30, 2025. | |
| Oct 19, 2025 | Heron Therapeutics HRTX | Option exercise 3,874 sh 2 days after the company's SCHEDULE 13D/A filed Oct 17, 2025. | 168,092 | 2 days after the company's SCHEDULE 13D/A filed Oct 17, 2025. | |
| Jul 31, 2025 | Heron Therapeutics HRTX | Option exercise 11,695 sh 43 days after the company's 8-K filed Jun 18, 2025. | 164,218 | 43 days after the company's 8-K filed Jun 18, 2025. | |
| Jul 19, 2025 | Heron Therapeutics HRTX | Option exercise 3,874 sh 31 days after the company's 8-K filed Jun 18, 2025. | 152,523 | 31 days after the company's 8-K filed Jun 18, 2025. | |
| Jun 24, 2025 | TerrAscend TSNDF | Award 433,653 sh 320 days after the company's 8-K filed Aug 8, 2024. | 657,930 | 320 days after the company's 8-K filed Aug 8, 2024. | |
| Jun 16, 2025 | Heron Therapeutics HRTX | Option exercise 12,500 sh 41 days after the company's S-8 filed May 6, 2025. | 148,649 | 41 days after the company's S-8 filed May 6, 2025. | |
| Apr 30, 2025 | Heron Therapeutics HRTX | Option exercise 11,694 sh The same day as the company's DEFA14A filed Apr 30, 2025. | 136,149 | The same day as the company's DEFA14A filed Apr 30, 2025. | |
| Apr 19, 2025 | Heron Therapeutics HRTX | Option exercise 3,875 sh 51 days after the company's 8-K filed Feb 27, 2025. | 124,455 | 51 days after the company's 8-K filed Feb 27, 2025. | |
| Jan 19, 2025 | Heron Therapeutics HRTX | Option exercise 3,874 sh 68 days after the company's 10-Q filed Nov 12, 2024. | 120,580 | 68 days after the company's 10-Q filed Nov 12, 2024. | |
| Dec 31, 2024 | TerrAscend TSNDF | Tax withholding 71,704 sh at $0.65 145 days after the company's 8-K filed Aug 8, 2024. | $47K | 224,277 | 145 days after the company's 8-K filed Aug 8, 2024. |
| Oct 19, 2024 | Heron Therapeutics HRTX | Option exercise 3,874 sh 165 days after the company's 8-K filed May 7, 2024. | 108,001 | 165 days after the company's 8-K filed May 7, 2024. | |
| Jul 19, 2024 | Heron Therapeutics HRTX | Option exercise 3,875 sh 73 days after the company's 8-K filed May 7, 2024. | 104,127 | 73 days after the company's 8-K filed May 7, 2024. | |
| Jun 17, 2024 | TerrAscend TSNDF | Award 163,334 sh | 295,981 | ||
| Jun 16, 2024 | Heron Therapeutics HRTX | Option exercise 12,500 sh 40 days after the company's 8-K filed May 7, 2024. | 100,252 | 40 days after the company's 8-K filed May 7, 2024. | |
| Apr 19, 2024 | Heron Therapeutics HRTX | Option exercise 3,874 sh The same day as the company's PRE 14A filed Apr 19, 2024. | 88,874 | The same day as the company's PRE 14A filed Apr 19, 2024. | |
| Apr 19, 2024 | Heron Therapeutics HRTX | Tax withholding 1,122 sh at $2.64 The same day as the company's PRE 14A filed Apr 19, 2024. | $3K | 87,752 | The same day as the company's PRE 14A filed Apr 19, 2024. |
| Nov 16, 2023 | Heron Therapeutics HRTX | Bought 85,000 sh at $0.89 Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. 157 days after the company's 8-K filed Jun 12, 2023. | $76K | 85,000 | Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. 157 days after the company's 8-K filed Jun 12, 2023. |
| Jun 22, 2023 | TerrAscend TSNDF | Award 132,647 sh | 132,647 | ||
| Feb 3, 2014 | Company with CIK 1145404 | Returned to company 7,000 sh at $9.50 | $67K | 0 | |
| Mar 7, 2013 | Company with CIK 1145404 | Award 7,000 sh | 7,000 |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.